|
1
|
Kabaria R, Klaassen Z and Terris MK: Renal
cell carcinoma: Links and risks. Int J Nephrol Renovasc Dis.
9:45–52. 2016.PubMed/NCBI
|
|
2
|
Capitanio U, Bensalah K, Bex A, Boorjian
SA, Bray F, Coleman J, Gore JL, Sun M, Wood C and Russo P:
Epidemiology of renal cell carcinoma. Eur Urol. 75:74–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou J, Yun EJ, Chen W, Ding Y, Wu K, Wang
B, Ding C, Hernandez E, Santoyo J, Pong RC, et al: Targeting
3-phosphoinositide-dependent protein kinase 1 associated with
drug-resistant renal cell carcinoma using new oridonin analogs.
Cell Death Dis. 8:e27012017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Campbell SC, Flanigan RC and Clark JI:
Nephrectomy in metastatic renal cell carcinoma. Curr Treat Options
Oncol. 4:363–372. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doberstein K, Steinmeyer N, Hartmetz AK,
Eberhardt W, Mittelbronn M, Harter PN, Juengel E, Blaheta R,
Pfeilschifter J and Gutwein P: MicroRNA-145 targets the
metalloprotease ADAM17 and is suppressed in renal cell carcinoma
patients. Neoplasia. 15:218–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Conti A, Santoni M, Amantini C, Burattini
L, Berardi R, Santoni G, Cascinu S and Muzzonigro G: Progress of
molecular targeted therapies for advanced renal cell carcinoma.
Biomed Res Int. 2013:4191762013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhat NS, Colden M, Dar AA, Saini S, Arora
P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S and Dahiya R:
MicroRNA-720 regulates E-cadherin-αE-catenin complex and promotes
renal cell carcinoma. Mol Cancer Ther. 16:2840–2848. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ying G, Wu R, Xia M, Fei X, He QE, Zha C
and Wu F: Identification of eight key miRNAs associated with renal
cell carcinoma: A meta-analysis. Oncol Lett. 16:5847–5855.
2018.PubMed/NCBI
|
|
11
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nilsson S, Möller C, Jirström K, Lee A,
Busch S, Lamb R and Landberg G: Downregulation of miR-92a is
associated with aggressive breast cancer features and increased
tumour macrophage infiltration. PLoS One. 7:e360512012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita
Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T,
Takahashi T, et al: miR-92a inhibits peritoneal dissemination of
ovarian cancer cells by inhibiting integrin alpha5 expression. Am J
Pathol. 182:1876–1889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ranade AR, Cherba D, Sridhar S, Richardson
P, Webb C, Paripati A, Bowles B and Weiss GJ: MicroRNA 92a-2*: A
biomarker predictive for chemoresistance and prognostic for
survival in patients with small cell lung cancer. J Thorac Oncol.
5:1273–1278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW,
Lee CW, Wong YN, Chan FK, Yu J and Sung JJ: Detection of miR-92a
and miR-21 in stool samples as potential screening biomarkers for
colorectal cancer and polyps. Gut. 61:739–745. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou C, Shen L, Mao L, Wang B, Li Y and Yu
H: miR-92a is upregulated in cervical cancer and promotes cell
proliferation and invasion by targeting FBXW7. Biochem Biophys Res
Commun. 458:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeh CH, Bellon M and Nicot C: FBXW7: A
critical tumor suppressor of human cancers. Mol Cancer. 17:1152018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for
ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wertz IE, Kusam S, Lam C, Okamoto T,
Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al:
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1
and FBW7. Nature. 471:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang H, Liu YH, Wang LL, Wang J, Zhao ZH,
Qu JF and Wang SF: MiR-182 promotes cell proliferation by
suppressing FBXW7 and FBXW11 in non-small cell lung cancer. Am J
Transl Res. 10:1131–1142. 2018.PubMed/NCBI
|
|
21
|
Hua J, Ding T and Yang L: Dysfunction of
microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma
disease. Onco Targets Ther. 9:6573–6579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SP, Alt AL, Weight CJ, Costello BA,
Cheville JC, Lohse C, Allmer C and Leibovich BC: Independent
validation of the 2010 American joint committee on cancer TNM
classification for renal cell carcinoma: Results from a large,
single institution cohort. J Urol. 185:2035–2039. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao Y, Yin C, Wang Y, Lv H, Wang W, Huang
Y, Perez-Losada J, Snijders AM, Mao JH and Zhang P: FBXW7 deletion
contributes to lung tumor development and confers resistance to
gefitinib therapy. Mol Oncol. 12:883–895. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu Y, Sengupta T, Kukreja L and Minella
AC: MicroRNA-223 regulates cyclin E activity by modulating
expression of F-box and WD-40 domain protein 7. J Biol Chem.
285:34439–34446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Tu K and Liu Q: Effects of
microRNA-30a on migration, invasion and prognosis of hepatocellular
carcinoma. FEBS Lett. 588:3089–3097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng
Y, Li M, Xia W, Feng D, Yin R and Xu L: A novel lncRNA, LUADT1,
promotes lung adenocarcinoma proliferation via the epigenetic
suppression of p27. Cell Death Dis. 6:e18582015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Borowicz S, Van Scoyk M, Avasarala S,
Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK and Winn RA: The
soft agar colony formation assay. J Vis Exp. e51998:2014.
|
|
30
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Z, Sun J, Liu B, Zhao M, Xing E and
Dang C: miRNA222 promotes liver cancer cell proliferation,
migration and invasion and inhibits apoptosis by targeting BBC3.
Int J Mol Med. 42:141–148. 2018.PubMed/NCBI
|
|
32
|
Pan BL, Wu L, Pan L, Yang YX, Li HH, Dai
YJ, He ZQ, Tan L, Huang YG, Tong ZW and Liao JL: Up-regulation of
microRNA-340 promotes osteosarcoma cell apoptosis while suppressing
proliferation, migration, and invasion by inactivating the
CTNNB1-mediated Notch signaling pathway. Biosci Rep.
38:BSR201716152018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jafri MA, Al-Qahtani MH and Shay JW: Role
of miRNAs in human cancer metastasis: Implications for therapeutic
intervention. Semin Cancer Biol. 44:117–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Venkatadri R, Muni T, Iyer AK, Yakisich JS
and Azad N: Role of apoptosis-related miRNAs in resveratrol-induced
breast cancer cell death. Cell Death Dis. 7:e21042016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sharifi M and Salehi R: Blockage of
miR-92a-3p with locked nucleic acid induces apoptosis and prevents
cell proliferation in human acute megakaryoblastic leukemia. Cancer
Gene Ther. 23:29–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Q, Teng Y, Wang R, Deng D, You Y,
Peng Y, Shao N and Zhi F: The long non-coding RNA SNHG14 inhibits
cell proliferation and invasion and promotes apoptosis by sponging
miR-92a-3p in glioma. Oncotarget. 9:12112–12124. 2018.PubMed/NCBI
|
|
38
|
Zhu S, Zhang L, Zhao Z, Fu W, Fu K, Liu G
and Jia W: MicroRNA92a3p inhibits the cell proliferation, migration
and invasion of Wilms tumor by targeting NOTCH1. Oncol Rep.
40:571–578. 2018.PubMed/NCBI
|
|
39
|
Lv XB, Zhang X, Deng L, Jiang L, Meng W,
Lu Z and Wang X: MiR-92a mediates AZD6244 induced apoptosis and
G1-phase arrest of lymphoma cells by targeting Bim. Cell Biol Int.
38:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mu Y, Zou H, Chen B, Fan Y and Luo S:
FAM83D knockdown regulates proliferation, migration and invasion of
colorectal cancer through inhibiting FBXW7/Notch-1 signalling
pathway. Biomed Pharmacother. 90:548–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen X, Li XY, Long M, Wang X, Gao ZW, Cui
Y, Ren J, Zhang Z, Liu C, Dong K and Zhang H: The FBXW7 tumor
suppressor inhibits breast cancer proliferation and promotes
apoptosis by targeting MTDH for degradation. Neoplasma. 65:201–209.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao J, Wang Y, Mu C, Xu Y and Sang J:
MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated
turnover of NICD1 in breast and ovarian cancer cells. Oncogene.
36:5023–5034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cai Y, Zhang M, Qiu X, Wang B, Fu Y, Zeng
J, Bai J and Yang G: Upregulation of FBXW7 suppresses renal cancer
metastasis and epithelial mesenchymal transition. Dis Markers.
2017:82769392017. View Article : Google Scholar : PubMed/NCBI
|
